Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study

P Ueda, H Svanström, M Melbye, B Eliasson… - bmj, 2018 - bmj.com
Objective To assess the association between the use of sodium glucose cotransporter 2
(SGLT2) inhibitors and seven serious adverse events of current concern. Design Register …
被引用次数：355 相关文章

Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study.

P Ueda, H Svanström, M Melbye, B Eliasson… - 2018 - cabidigitallibrary.org
Objective: To assess the association between the use of sodium glucose cotransporter 2
(SGLT2) inhibitors and seven serious adverse events of current concern. Design: Register …
[HTML] bmj.com

[HTML][HTML] Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study

P Ueda, H Svanström, M Melbye, B Eliasson… - BMJ, 2018 - bmj.com
Objective To assess the association between the use of sodium glucose cotransporter 2
(SGLT2) inhibitors and seven serious adverse events of current concern. Design Register …

Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study

P Ueda, H Svanström, M Melbye, B Eliasson… - BMJ, 2018 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Objective</jats: title>< jats: p> To
assess the association between the use of sodium glucose cotransporter 2 (SGLT2) …
[PDF] researchgate.net

[PDF][PDF] Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study

P Ueda, H Svanström, M Melbye, B Eliasson… - bmj, 2018 - researchgate.net
Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide
register based cohort study Page 1 the bmj | BMJ 2018;363:k4365 | doi: 10.1136/bmj.k4365 …

Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study.

P Ueda, H Svanström, M Melbye… - … (Clinical Research ed …, 2018 - europepmc.org
Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide
register based cohort study. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study

P Ueda, H Svanström, M Melbye… - BMJ (Clinical …, 2018 - pubmed.ncbi.nlm.nih.gov
Objective To assess the association between the use of sodium glucose cotransporter 2
(SGLT2) inhibitors and seven serious adverse events of current concern. Design Register …
[HTML] nih.gov

[HTML][HTML] Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study

P Ueda, H Svanström, M Melbye, B Eliasson… - The BMJ, 2018 - ncbi.nlm.nih.gov
Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide
register based cohort study - PMC Back to Top Skip to main content NIH NLM Logo Access keys …
[PDF] core.ac.uk

[PDF][PDF] Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study

P Ueda, H Svanström, M Melbye, B Eliasson… - bmj, 2018 - core.ac.uk
Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide
register based cohort study Page 1 univERsity oF copEnhAGEn Sodium glucose cotransporter 2 …

Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events

P Ueda, H Svanström, M Melbye, B Eliasson… - BMJ: British Medical …, 2018 - JSTOR
OBJECTIVE To assess the association between the use of sodium glucose cotransporter 2
(SGLT2) inhibitors and seven serious adverse events of current concern. DESIGN Register …